Bayer and Evotec to Upgrade Precision Cardiology
Bayer and Evotec have updated the focus of their strategic collaboration to developing innovative precision treatments for cardiovascular diseases (CVDs).
Precision Treatments | 01/05/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy